Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer • Medical Oncology
Would you give adjuvant nivolumab for IIIA melanoma?
Patients with T3aN1a( stage IIIA per AJCC7) were excluded from nivolumab adjuvant trial. Would you consider nivolumab in these patients?
Answer from: Medical Oncologist at Academic Institution
This is a very timely and excellent question. There have been recently three landmark adjuvant studies, and two recent FDA approvals that have changed our approach for patients with resected melanoma. All three studies were based on AJCC staging 7th edition and required patients to undergo complete ...
Sign in or Register to read more